GSK Pharma parent makes open offer
  • 6 years ago
GlaxoSmithKline made an open offer to buy back as 20.61 million shares of publicly traded GlaxmSmithKline Pharmaceuticals, valuing the purchase at Rs6,400 crore. Mint's Malvika Joshi has more details.